Bristol-Myers Squibb BMY
CEO: Chris Boerner · Pharmaceuticals · 34,300 employees
D
Pay-for-Performance
35/100
$22.6M
CEO Total Comp
412:1
CEO-Worker Ratio
72.2%
Say-on-Pay Vote
-6.5%
3yr TSR
$55K
Median Worker Pay
Compensation Breakdown
Salary$1.9M
Bonus$683K
Stock Awards$14.3M
Options$3.0M
Non-Equity Incentive$2.4M
Pension$179K
Other$140K
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.9M | $683K | $14.3M | $3.0M | $2.4M | $140K | $22.6M |
| 2024 | $1.9M | — | $12.9M | $2.8M | $2.4M | $28K | $20.1M |
| 2023 | $1.9M | $220K | $7.2M | $3.1M | $1.7M | $88K | $14.4M |
| 2022 | $1.8M | — | $10.9M | $3.1M | $1.1M | $111K | $17.4M |